IL32 and neoplasm: Thus, we implanted 1 × 106 INA-6 iRFP-labelled IL-32 KO and WT cells into humanized bone scaffolds in immune compromised female RAG2−/− GC−/−mice and followed tumor growth by imaging (Groen et al., 2012; Westhrin et al., 2020).